Home NDC 0069-0305 Trazimera
Product NDC 0069-0305
11-digit product format 000690305
Labeler code 0069
Product ID 0069-0305_6bb3d11b-6f9e-408c-a957-b7bacaf9e175
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name trastuzumab-qyyp
Dosage form KIT
Labeler Pfizer Laboratories Div Pfizer Inc
Application BLA761081
Marketing category BLA
Marketing start 2020-02-24
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Trazimera
Listing expiration 2027-12-31 Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination P188ANX8CK Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2280732 Internal RxNorm lookup 2280737 Internal RxNorm lookup 2472791 Internal RxNorm lookup 2472794 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0069-0305-01 Trazimera 1 in 1 KIT KIT 1 9 0069-0306-01 Trazimera 20 mL in 1 VIAL, MULTI-DOSE INJECTION, POWDER, LYOPHILIZED, 20 mL 420 mg in 20mL 9
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0069-0305 TRAZIMERA (TRASTUZUMAB-QYYP) KIT TRAZIMERA (TRASTUZUMAB-QYYP) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] 7 Current NDC, Legacy NDC, 2 package rows 20241222_b9c5e894-27d2-4245-a653-df986fed3c56.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Trazimera TRASTUZUMAB-QYYP Pfizer Laboratories Div Pfizer Inc b9c5e894-27d2-4245-a653-df986fed3c56 2026-04-10 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA761081 ndc (product): 0069-0305
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761081 Trazimera trastuzumab-qyyp 351(k) Biosimilar Rx 2026-07-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0069-0305-01 00069030501 1 KIT in 1 KIT (0069-0305-01) * 20 mL in 1 VIAL, MULTI-DOSE (0069-0306-01) * 20 mL in 1 VIAL (0069-0307-01) 1 kit 2020-02-24 0000-00-00 No No Current 0069-0306-01 00069030601 20 mL in 1 VIAL, MULTI-DOSE 20 ml Historical